AVA Investment Analytics (AVAIA) is the public markets division of Apex Venture Advisors, LLC.
AVAIA is overseen by Mike Stathis, our Chief Investment Strategist. AVAIA is a results-driven research and publishing firm focusing on serving institutional investors. Research leading to the formation of AVAIA began in 2003 through the formation of Apex Venture Advisors.
Two years later our research was expanded from the private markets to include the public markets and AVA Investment Analytics was created as a business unit from within Apex Venture Advisors.
We have worked with the following types of clients:
- Corporate Treasury Departments
- Pension Funds
- Financial Institutions
- Hedge Funds
- Private Equity Firms
- Venture Capital Firms
- Mutual Funds
- Family Investment Offices
- High-Net Worth Investors
- Financial Advisers
- Investment Analysts
- Investment Bankers
About Mike Stathis
Mike is the Principal and Chief Investment Strategist of AVA Investment Analytics. He oversees all investment consultations to institutional investors. He is also the Managing Principal of Apex Venture Advisors, the parent company of AVAIA.
Mike previously worked for UBS and Bear Stearns in asset management and merchant banking. where he dealt with institutional investors, including corporate treasury departments and pension funds. He was the only professional in private client services at Bear Stearns to also hold a position in the biotechnology merchant banking department. He has personally managed hundreds of investment accounts, served as an adviser to venture capital firms, and worked with numerous entrepreneurs.
As the only expert who predicted the financial apocalypse in detail, Mike has been a valuable source of guidance for investors, helping them to navigate the real estate and banking crisis, as well as the resulting global economic collapse. The accuracy of his predictions has positioned him as one of America’s most insightful and creative financial experts.
He is the author of
America’s Healthcare Solution
The Wall Street Investment Bible
America’s Financial Apocalypse
Cashing in on the Real Estate Bubble and
The Startup Company Bible for Entrepreneurs
Prior to his work at UBS and Bear Stearns, Mike completed more than 800 college credit hours in the sciences, including countless graduate level courses in chemistry, physics, mathematics, biochemistry, genetics, molecular biology, immunology, physiology and pathology.
He holds a Masters of Science in biophysics and biological chemistry and a minor in mathematics, and was a National Science Foundation Research Fellow where he performed research in solid state physics. He has also performed chemistry research in oil, as well as alternative energy (theoretical aspects of solar and hydrogen fuel).
He also taught a course which he designed himself on biotechnology at Southern Methodist University.
His investment expertise spans several industries, but his technology focus in both the public and private markets is healthcare (including healthcare IT) and biopharma.
Internships and Employment
Please see here for information about internships and employment opportunities